Vitamin D and Reduced Anti-thyroglobulin Antibody Level

Doses used in studies

IU/week: 2,800–60,000 (median 31,400, IQR 2,800–60,000) — 1 study

Time to effect

Median: 3 months · IQR 3 months–3 months · Range 3 months–3 months — Reported in 1 of 1 study

1 of 1 paper

The impacts of vitamin D supplementation on serum levels of thyroid autoantibodies in patients with autoimmune thyroid disease: a meta-analysis.

2025-06-16
Meta-Analysis · n = 577
PeerJ 13
- Dongdong Luo
- Bojuan Li
- Zhongyan Shan
- Weiping Teng
- Qigui Liu
- Jing Li

PubMed: 40538736
DOI: 10.7717/peerj.19541

2 Insights on

Reduced Anti-thyroglobulin Antibody Level

High evidence
Rigorous Journal
Clinical

serum TPOAb and TgAb titers were significantly decreased in the patients receiving VitD supplementation for at least 3 months, but not in the ones for less than 3 months

Effect: Beneficial
Effect size: Moderate
Significant: Yes
Dose: 2800-60000 IU/week for at least 3 months